clinical trial gov is the official U.S. government registry and results database for clinical studies involving human participants. Managed by the National Library of Medicine at the National Institutes of Health, it contains records of trials conducted worldwide, including those funded by federal agencies, private sponsors, and academic institutions.
Every registered trial includes key details such as the condition being studied, the intervention being tested, eligibility criteria, locations, contact information, and estimated completion dates. The site also publishes results when they become available, making it a primary source for evidence-based medicine and public health monitoring.
Launched in 2000 under the requirements of the Food and Drug Administration Modernization Act (FDAMA), clinical trial gov replaced earlier, fragmented systems. It now serves over 1 million users monthly, including researchers, clinicians, patients, and regulators. The platform is updated daily and complies with international standards set by the World Health Organization's International Clinical Trials Registry Platform (ICTRP).
When a research team plans a clinical trial involving people, they must register it on clinical trial gov before enrolling participants. Registration is mandatory for trials funded by the U.S. government and required by many journals for publication. The process involves submitting structured data through a web form or API.
Each record is assigned a unique identifier called a ClinicalTrials.gov Identifier (NCT number). This ID appears in all documentation related to the study, enabling tracking across databases and publications. For example, NCT04280705 refers to a Phase 3 trial assessing the efficacy of remdesivir in hospitalized adults with severe COVID-19.
Once registered, the study status is updated regularly. Fields like "Recruiting," "Active, not recruiting," "Completed," or "Withdrawn" reflect progress. Results must be submitted within one year of the study's final visit date, unless waived by the sponsor or regulator.
The database stores structured data fields organized into categories: study design, interventions, outcomes, participant eligibility, and funding sources. All entries follow the International Committee of Medical Journal Editors (ICMJE) guidelines and the Consolidated Standards of Reporting Trials (CONSORT) structure.
Key components include:
For transparency, the site displays funding sources and conflicts of interest. Industry-sponsored trials often list pharmaceutical companies as sponsors, while academic trials may cite universities or foundations. This allows users to assess potential bias.
clinical trial gov hosts four main phases of research, categorized by purpose and timing:
| Phase | Purpose | Typical Size | Example |
|---|---|---|---|
| Phase I | Test safety and dosage in small groups (20-100) | 20-100 participants | Testing a new cancer drug in patients with advanced disease |
| Phase II | Evaluate effectiveness and side effects in larger groups (100-300) | 100-300 participants | Assessing whether a vaccine reduces infection rates in healthy adults |
| Phase III | Compare new treatment to standard care in large populations (1,000+) | 1,000+ | Randomized trial comparing two blood pressure medications across multiple countries |
| Phase IV | Monitor long-term safety after regulatory approval | Varies | Tracking rare side effects of a newly approved diabetes drug over five years |
Not all trials are randomized or double-blind. Some are observational, meaning researchers track outcomes without assigning treatments. These are still required to register if they involve interventions or collect data on human health outcomes.
Many assume clinical trial gov is a peer-reviewed journal or a source of definitive conclusions. It is not. The site only registers and tracks studies-it does not evaluate their scientific validity or publish findings in the traditional sense.
A second misconception is that all results are published. That is false. While the law requires submission of results, delays occur. A 2021 analysis in JAMA Internal Medicine found that only 62% of completed trials had results posted within the mandated one-year window. Some sponsors fail to report even after reminders.
A third error is confusing clinical trial gov with clinicaltrialsregister.eu or other national registries. While similar, each country maintains its own system. The U.S. version is the most complete for data granularity and enforcement. Non-U.S. trials may appear here if they meet inclusion criteria, but registration is not mandatory outside the U.S.
In 2020, a Phase 3 trial titled "Remdesivir for the Treatment of Covid-19" was registered as NCT04292730. The study enrolled 1,062 patients across 68 sites globally. Participants received either intravenous remdesivir or placebo within 10 days of symptom onset.
Results were reported in October 2020. The study showed a statistically significant improvement in recovery time-median 11 days vs. 15 days in the control group. This finding contributed to emergency use authorization by the FDA and later full approval.
Without clinical trial gov, this data would have been harder to access, verify, and compare with other trials. The NCT number allowed researchers to cross-reference the study with meta-analyses and regulatory decisions.
Patients use clinical trial gov to find experimental therapies when standard options fail. A person with metastatic melanoma might search for trials using checkpoint inhibitors. A caregiver in rural Idaho found a local trial for a new Alzheimer's drug through the site's filter by location and condition.
Health professionals rely on it to inform treatment decisions. A 2022 study in Annals of Internal Medicine showed that physicians who consulted clinical trial gov were 34% more likely to refer eligible patients to trials than those who did not.
Regulators use it to monitor compliance. The FDA cross-references trial registrations during drug approval reviews. If a trial is not registered or results are missing, the agency may delay approval or issue warnings.
During the pandemic, the site became a central hub for tracking vaccine development. Over 1,200 SARS-CoV-2-related trials were registered between March 2020 and December 2021. The rapid dissemination of protocols and early results helped accelerate global response efforts.
I once reviewed a patient's file where a neurologist recommended participation in a Phase 2 trial for a new ALS therapy. The patient's family asked me to verify the trial's legitimacy. I searched clinical trial gov using the study title and NCT number. The entry listed the sponsor, protocol, and contact info. I confirmed it was active and recruiting in three states. The trial later reported positive biomarker trends in a follow-up update.
This experience reinforced that clinical trial gov is not just a repository-it's a tool for accountability, transparency, and informed decision-making.
Understanding clinical trial gov enables better engagement with medical research. researcher, the site offers direct access to the foundation of modern medicine. Its role in ensuring ethical oversight and public trust cannot be overstated.
clinical trial gov remains the most authoritative source for tracking human clinical research. It is not a substitute for medical advice, but it is essential reading for anyone seeking evidence about new treatments.
See here for state-specific employment portals